Japan
# |
Name |
Gross Profit Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
100.00%
|
Sept. 30, 2024 | USD 7.09 | 6.47% |
|
Japan |
|
2 |
97.97%
|
July 31, 2023 | USD 1.94 | -0.83% |
|
Japan |
|
3 |
96.58%
|
June 30, 2024 | USD 4.01 | -3.09% |
|
Japan |
|
4 |
91.44%
|
Dec. 31, 2023 | USD 1.00 | -3.25% |
|
Japan |
|
5 |
89.66%
|
Dec. 31, 2023 | USD 0.52 | 1.05% |
|
Japan |
|
6 |
89.22%
|
Dec. 31, 2023 | USD 1.82 | 0.52% |
|
Japan |
|
7 |
87.33%
|
March 31, 2024 | USD 3.73 | -2.66% |
|
Japan |
|
8 |
87.11%
|
Dec. 31, 2023 | USD 2.46 | -0.69% |
|
Japan |
|
9 |
86.24%
|
Dec. 31, 2023 | USD 19.77 | 1.11% |
|
Japan |
|
10 |
85.06%
|
March 31, 2024 | USD 3.43 | 17.10% |
|
Japan |
|
11 |
84.83%
|
March 31, 2024 | USD 14.22 | -0.40% |
|
Japan |
|
12 |
82.82%
|
March 31, 2024 | USD 5.61 | 0.04% |
|
Japan |
|
13 |
81.88%
|
March 31, 2024 | USD 0.90 | -4.23% |
|
Japan |
|
14 |
80.63%
|
March 31, 2024 | USD 3.22 | 1.41% |
|
Japan |
|
15 |
79.45%
|
Sept. 30, 2024 | USD 12.19 | -2.76% |
|
Japan |
|
16 |
79.06%
|
March 31, 2024 | USD 27.10 | 0.38% |
|
Japan |
|
17 |
78.91%
|
Dec. 31, 2023 | USD 1.27 | -1.66% |
|
Japan |
|
18 |
78.82%
|
July 31, 2024 | USD 2.79 | -1.08% |
|
Japan |
|
19 |
78.45%
|
July 31, 2024 | USD 6.07 | -3.40% |
|
Japan |
|
20 |
78.38%
|
Dec. 31, 2023 | USD 2.71 | -1.34% |
|
Japan |
|
21 |
75.70%
|
Dec. 31, 2023 | USD 6.14 | -1.80% |
|
Japan |
|
22 |
75.60%
|
March 31, 2024 | USD 9.60 | 0.25% |
|
Japan |
|
23 |
75.47%
|
March 31, 2024 | USD 8.38 | -2.25% |
|
Japan |
|
24 |
75.30%
|
March 31, 2024 | USD 6.87 | -1.00% |
|
Japan |
|
25 |
74.85%
|
Dec. 31, 2023 | USD 14.74 | 1.56% |
|
Japan |
|
26 |
74.71%
|
March 31, 2024 | USD 10.35 | 0.21% |
|
Japan |
|
27 |
74.07%
|
March 31, 2024 | USD 26.30 | 0.47% |
|
Japan |
|
28 |
73.47%
|
Dec. 31, 2023 | USD 9.59 | -1.93% |
|
Japan |
|
29 |
72.90%
|
March 31, 2024 | USD 3.68 | -2.20% |
|
Japan |
|
30 |
70.60%
|
Oct. 31, 2023 | USD 5.00 | -4.99% |
|
Japan |
|
31 |
70.47%
|
March 31, 2024 | USD 1.55 | 3.19% |
|
Japan |
|
32 |
69.79%
|
March 31, 2024 | USD 4.63 | 3.21% |
|
Japan |
|
33 |
69.72%
|
Dec. 31, 2023 | USD 50.94 | -0.33% |
|
Japan |
|
34 |
69.67%
|
March 31, 2024 | USD 2.06 | -4.87% |
|
Japan |
|
35 |
67.62%
|
Sept. 30, 2024 | USD 29.61 | -0.61% |
|
Japan |
|
36 |
67.58%
|
March 31, 2024 | USD 10.09 | -0.56% |
|
Japan |
|
37 |
67.58%
|
July 31, 2024 | USD 2.66 | -2.04% |
|
Japan |
|
38 |
67.26%
|
March 31, 2024 | USD 7.47 | -1.19% |
|
Japan |
|
39 |
67.26%
|
April 30, 2024 | USD 0.94 | -5.30% |
|
Japan |
|
40 |
67.24%
|
March 31, 2024 | USD 3.02 | 0.87% |
|
Japan |
|
41 |
66.75%
|
Sept. 30, 2024 | USD 6.90 | -1.98% |
|
Japan |
|
42 |
66.43%
|
March 31, 2024 | USD 26.08 | -0.18% |
|
Japan |
|
43 |
66.27%
|
March 31, 2024 | USD 14.08 | -1.34% |
|
Japan |
|
44 |
65.44%
|
March 31, 2024 | USD 24.53 | -2.23% |
|
Japan |
|
45 |
65.39%
|
Dec. 31, 2023 | USD 2.12 | -0.48% |
|
Japan |
|
46 |
64.60%
|
June 30, 2024 | USD 3.90 | -1.46% |
|
Japan |
|
47 |
64.45%
|
March 31, 2024 | USD 5.18 | 0.43% |
|
Japan |
|
48 |
64.21%
|
June 30, 2024 | USD 15.87 | -0.88% |
|
Japan |
|
49 |
64.13%
|
Dec. 31, 2023 | USD 5.55 | 1.55% |
|
Japan |
|
50 |
63.69%
|
March 31, 2024 | USD 3.76 | -0.68% |
|
Japan |
The Pharmaceuticals company in Japan with the highest Gross Profit Margin is Kringle Pharma, Inc. (Tokyo Stock Exchange: 4884.T) at 100.00%.
The Pharmaceuticals company in Japan with the lowest Gross Profit Margin is FunPep Company Limited (Tokyo Stock Exchange: 4881.T) at -128,356.04%.
The top 10 Pharmaceuticals companies in Japan by Gross Profit Margin are Kringle Pharma, Inc., StemRIM, SUSMED,Inc., D. Western Therapeutics Institute, Inc., MedRx Co., Ltd, Carna Biosciences, Inc., Perseus Proteomics Inc., RaQualia Pharma Inc., GNI Group Ltd. and Renascience Inc..
The bottom 10 Pharmaceuticals companies in Japan by Gross Profit Margin are FunPep Company Limited, BrightPath Biotherapeutics Co., Ltd., Kubota Pharmaceutical Holdings Co., Ltd., OncoTherapy Science, Inc., Tsubota Laboratory Incorporated, Ohki Healthcare Holdings Co.,Ltd., MediPal Holdings Corporation, Alfresa Holdings Corporation, Paltac Corporation and Suzuken Co., Ltd..